We are a clinical-stage biopharmaceutical company focused on significantly improving treatment outcomes for patients with cancer. Utilizing our proprietary phosphoramidate technology we are developing more effective and safer anti-cancer medicines.

NuCana is led by a highly experienced management team with extensive drug development & commercialization expertise.

Mission Statement

“To significantly improve the survival outcomes for patients and pioneer a new era in oncology”.

Hugh S. Griffith - Founder & CEO

Discover more